KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Interest Expenses (2016 - 2022)

Resmed (RMD) has disclosed Interest Expenses for 7 consecutive years, with $5.5 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Interest Expenses fell 6.2% year-over-year to $5.5 million, compared with a TTM value of $5.5 million through Dec 2022, down 75.7%, and an annual FY2021 reading of $24.0 million, down 40.59% over the prior year.
  • Interest Expenses was $5.5 million for Q1 2022 at Resmed, down from $5.9 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $12.5 million in Q2 2019 and bottomed at $3.7 million in Q3 2018.
  • Average Interest Expenses over 5 years is $7.7 million, with a median of $6.7 million recorded in 2020.
  • The sharpest move saw Interest Expenses plummeted 52.37% in 2018, then surged 196.44% in 2019.
  • Year by year, Interest Expenses stood at $7.5 million in 2018, then surged by 36.5% to $10.2 million in 2019, then crashed by 42.04% to $5.9 million in 2020, then increased by 0.41% to $5.9 million in 2021, then dropped by 8.17% to $5.5 million in 2022.
  • Business Quant data shows Interest Expenses for RMD at $5.5 million in Q1 2022, $5.9 million in Q4 2021, and $5.4 million in Q3 2021.